PsychEd Episode 30: Anti-black Racism and Mental Health with Dr. Kwame McKenzie
Play • 1 hr 5 min

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers anti-black racism and mental health with Dr. Kwame McKenzie. Dr. McKenzie is an international expert on the social causes of illness, suicide and the development of effective, equitable health systems. He is a Professor of Psychiatry at University of Toronto and a staff psychiatrist and Director of Health Equity at the Centre of Addiction and Mental Health.


The learning objectives:


By the end of this episode, you should be able to…

  1. Understand the history and legacy of racism and mental health in the black community
  2. Understand the current state of racism towards black people and the impacts on their mental health.
  3. Explore how healthcare workers can be anti-racist in providing mental health care and how the system can change to improve the mental health of black people.


Host(s): Anita Corsini (social worker), Dr. Alex Raben (staff psychiatrist), and Rebecca Marsh (CC4)


Produced by: Anita Corsini, Rebecca Marsh, Randi Wang (CC4), and Dr. Alex Raben


Guest experts: Dr. Kwame McKenzie, staff psychiatrist




Manual for Cognitive-Behavioural Therapy for English-Speaking People of Caribbean Origin

The City of Toronto has curated a list of Mental Health Resources for Black Communities. Organizations include:




  • Adelman, J. (2003). Study in Blue and Grey, Police Interventions with People with Mental Illness: A Review of Challenges and Responses [Ebook]. Canadian Mental Health Association. Retrieved 7 October 2020, from
  • Bailey, R. K., Mokonogho, J., & Kumar, A. (2019). Racial and ethnic differences in depression: current perspectives. Neuropsychiatric disease and treatment, 15, 603–609.
  • Bor, J., Venkataramani, A., Williams, D., & Tsai, A. (2018). Police killings and their spillover effects on the mental health of black Americans: a population-based, quasi-experimental study. The Lancet, 392(10144), 302-310.
  • Bresnahan, M., Begg, M., Brown, A., Schaefer, C., Sohler, N., & Insel, B. et al. (2007). Race and risk of schizophrenia in a US birth cohort: another example of health disparity?. International Journal Of Epidemiology, 36(4), 751-758.
  • Chakraborty, A., McKenzie, K., & King, M. (2009). Discrimination, ethnicity and psychosis — a qualitative study. Ethnicity And Inequalities In Health And Social Care, 2(1), 18-29.
  • Fernando, S. (2014). Racism in psychiatry. In R. Moodley & M. Ocampo (Eds.), Critical Psychiatry and Mental Health: Exploring the Work of Suman Fernando in Clinical Practice (pp. 22-32). Taylor & Francis.  
  • Kirkmayer, L. J. (2014). Critical psychiatry in Canada. In R. Moodley & M. Ocampo (Eds.), Critical Psychiatry and Mental Health: Exploring the Work of Suman Fernando in Clinical Practice (pp. 170-181). Taylor & Francis.  
  • Kuper, A. (2018). Cultural Safety & Equity [Lecture PDF]. Retrieved from University of Toronto Faculty of Medicine. 
  • Maynard, R. (2017). Policing Black Lives: State Violence in Canada from Slavery to the Present. Fernwood.
  • McKenzie, K. (2002). Does racial discrimination cause mental illness?. European Psychiatry, 17, 84.
  • McKenzie, K., & Bhui, K. (2007). Institutional racism in mental health care. BMJ, 334(7595), 649-650.
  • MCRRT - St. Joseph's Healthcare Hamilton. St. Joseph's Healthcare Hamilton. (2020). Retrieved 7 October 2020, from
  • Richardson, L. (2019). Diversity and Advocacy [Lecture PDF]. Retrieved from University of Toronto Faculty of Medicine. 

CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.

For more PsychEd, follow us on Twitter (@psychedpodcast) and Facebook. You can provide feedback by email at  For more information visit our website:

Bedside Rounds
Bedside Rounds
Adam Rodman, MD, MPH, FACP
60 - Santa's Salmonella
For a special holiday treat, we’re going to explore two tales of salmonella disease detectives -- the first about Mary Mallon (“Typhoid Mary”) and the birth of the genre; and the second about a mysterious salmonella outbreak at Massachusetts General Hospital solved with the assistance of a very jolly patient. Along the way, we’ll talk about clinical epidemiology, the long-lasting influence of Berton Roueché, and the joys of being an internist! You can sign up for the Digital Education conference at Sources: * Buckle GC, Fischer Walker CL, and Black RE, Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010.J Glob Health. 2012 Jun; 2(1): 010401. * Marineli F et al, Mary Mallon (1869-1938) and the history of typhoid fever.Ann Gastroenterol. 2013; 26(2): 132–134. * Soper GA, The Curious Career of Typhoid Mary, read on May 10, 1939 before the Section of Historical and Cultural Medicine. Retrieved from: * Norrington B, Cochineal: A Little Insect Goes a Long Way, UCSB Geography. * Roueche B, The Santa Claus Culture, The New Yorker, Aug 27, 1971. * Lang DJ et al, Carmine as a Source of Nosocomial Salmonellosis, NEJM. Apr 13, 1967. * You can buy Medical Detectives here:
38 min
BrainWaves: A Neurology Podcast
BrainWaves: A Neurology Podcast
Jim Siegler, MD | Neurologist | Father | Friend of dogs
#177 Agnosia
To quote Donald Rumsfeld, “there are things we know we know…. we know there are some things we do not know... But there are also unknown unknowns—the ones we don't know we don't know…it is the latter category that tends to be the difficult ones.” In neurology, the agnosias are not that dissimilar from Rumsfeld’s 'unknown unknowns.' In this week’s program, we discuss the nosology and nomenclature for the agnosias, the localization, and the importance of recognizing one. Produced by James E. Siegler. Music courtesy of Dr. Turtle, Grossman, Ewell and Grainger, Marco Trovatelli, and Purple Planet Music. The opening theme was composed by Jimothy Dalton. Sound effects by Mike Koenig and Daniel Simion. Unless otherwise mentioned in the podcast, no competing financial interests exist in the content of this episode. BrainWaves' podcasts and online content are intended for medical education only and should not be used for clinical decision making. Be sure to follow us on Twitter @brainwavesaudio for the latest updates to the podcast. REFERENCES * Milner AD, Perrett DI, Johnston RS, Benson PJ, Jordan TR, Heeley DW, Bettucci D, Mortara F, Mutani R, Terazzi E and et al. Perception and action in 'visual form agnosia'. Brain. 1991;114 ( Pt 1B):405-28. * Zeki S and Ffytche DH. The Riddoch syndrome: insights into the neurobiology of conscious vision. Brain. 1998;121 ( Pt 1):25-45. * Biran I and Coslett HB. Visual agnosia. Current neurology and neuroscience reports. 2003;3:508-12. * Coslett HB. Apraxia, Neglect, and Agnosia. Continuum (Minneap Minn). 2018;24:768-782. * Dhont S, Derom E, Van Braeckel E, Depuydt P and Lambrecht BN. The pathophysiology of 'happy' hypoxemia in COVID-19. Respir Res. 2020;21:198. * Li YC, Bai WZ and Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92:552-555. * Matschke J, Lutgehetmann M, Hagel C, Sperhake JP, Schroder AS, Edler C, Mushumba H, Fitzek A, Allweiss L, Dandri M, Dottermusch M, Heinemann A, Pfefferle S, Schwabenland M, Sumner Magruder D, Bonn S, Prinz M, Gerloff C, Puschel K, Krasemann S, Aepfelbacher M and Glatzel M. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. The Lancet Neurology. 2020;19:919-929.
15 min
American Journal of Psychiatry Audio
American Journal of Psychiatry Audio
American Journal of Psychiatry
March 2021: Psychiatry Diversity Leadership in Academic Medicine
Executive Editor Michael Roy speaks with Ayana Jordan, M.D., Ph.D., and Christina Mangurian, M.D., M.A.S., about their article on psychiatry diversity leadership in academic medicine. Dr. Ayana Jordan is an associate program director of the adult psychiatry training program and an assistant professor of psychiatry at the Yale University School of Medicine. She is a member of the APA Board of Trustees, and she serves on the Early-Career Psychiatrist Advisory Committee for the journal Psychiatric Services. Her research is concentrated on increasing access to care for minoritized populations with substance use problems. Dr. Christina Mangurian is a professor of psychiatry, epidemiology, and biostatistics in the School of Medicine at the University of California, San Francisco (UCSF). She is also vice chair for diversity and health equity at the UCSF Department of Psychiatry and Behavioral Sciences and a former chair of the APA Council on Minority Mental Health and Health Disparities. Her primary research program focuses on promoting mental health equity for patients and the workforce. * The authors’ background and how they became involved in their work [2:50] * How the authors’ roles in the workplace and in the community changed over the course of the past few years [7:51] * Description of the case vignette presented in the article [14:23] * The overall landscape for diversity leaders at psychiatry departments [18:40] * Comparisons with other fields of medicine and academia [22:20] * Three unique challenges faced by individuals who hold diversity, equity, and inclusion (DEI) roles [24:44] * Initial steps that can help leaders in DEI positions [28:42] * What people with institutional power can do to make sure that the experiences of BIPOC individuals are not ignored [34:40] * Best practices to effectively support DEI leadership efforts in psychiatry [37:18] * How scholarly research can adapt to help advance these efforts [42:39] * Are the authors optimistic that we can overcome barriers and make real progress in efforts to expand diversity, equity, and inclusion throughout our community and workplaces? [46:11] Photo (from top): Helena Hansen, M.D., Ph.D., Christina Mangurian, M.D., M.A.S., Carolyn I. Rodriguez, M.D., Ph.D., Ayana Jordan, M.D., Ph.D., Ruth S. Shim, M.D., M.P.H., Altha J. Stewart, M.D. (Image courtesy of Dr. Mary Kay Smith.) Full author list of the article: Ayana Jordan, M.D., Ph.D. (Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.) Ruth S. Shim, M.D., M.P.H. (Department of Psychiatry, University of California, Davis) Carolyn I. Rodriguez, M.D., Ph.D. (Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, Calif., and Veterans Affairs Palo Alto Health Care System, Palo Alto, Calif.) Eraka Bath, M.D. (Department of Psychiatry, Division of Child and Adolescent Psychiatry, University of California, Los Angeles) Jean-Marie Alves-Bradford, M.D. (Department of Psychiatry, Columbia University, and New York State Psychiatric Institute, New York) Lisa Eyler, Ph.D. (Department of Psychiatry, University of California, San Diego, and Desert-Pacific Mental Illness Research, Education, and Clinical Center, VA San Diego Healthcare Center, San Diego) Nhi-Ha Trinh, M.D. (Department of Psychiatry, Massachusetts General Hospital and Harvard University School of Medicine, Boston) Helena Hansen, M.D., Ph.D. (Departments of Psychiatry and Anthropology, New York University, New York) Christina Mangurian, M.D., M.A.S. (Department of Psychiatry and Behavioral Sciences and Department of Biostatistics and Epidemiology, University of California, San Francisco (UCSF), UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General, and UCSF Philip R. Lee Institute for Health Policy Studies, San Francisco) Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Stitcher, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. Watch Deputy Editor Daniel S. Pine, M.D., present highlights from the March 2021 issue. Follow the journals of APA Publishing on Twitter. E-mail us at
51 min
The Carlat Psychiatry Podcast
The Carlat Psychiatry Podcast
Pocket Psychiatry: A Carlat Podcast
Duty to Warn: Antidepressants in Children and Adolescents
For nearly 17 years, since the FDA black box warning about suicidality with antidepressants, our community has been quoting data that downplays this concern. We were wrong. We were deceived. Antidepressants can be lifesaving, but there really is a duty to warn. In this episode, Doctors Martha Ignaszewski and Glen Spielmans talk with us about what went on and how to talk about it with our families. Guests: * Dr. Glen Spielmans, professor of psychology at Metropolitan State University in Saint Paul, Minnesota * Dr. Martha Ignaszewski, staff psychiatrist at BC Children’s Hospital and a clinical instructor at the University of British Columbia Published On: 3/1/2021 Duration: 24 minutes, 36 seconds Related Articles: * "Duty to Warn? Debating Antidepressant Suicidality,"_ The Carlat Child Psychiatry Report_, Oct/Nov/Dec 2020 * Spielmans GI, Spence-Sing T, Parry P. Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified. _Front Psychiatry_. 2020 Feb 13;11:18. doi: 10.3389/fpsyt.2020.00018. PMID: 32116839; PMCID: PMC7031767. [Link] * Ignaszewski MJ, Waslick B. Update on Randomized Placebo-Controlled Trials in the Past Decade for Treatment of Major Depressive Disorder in Child and Adolescent Patients: A Systematic Review. _J Child Adolesc Psychopharmacol_. 2018 Dec;28(10):668-675. doi: 10.1089/cap.2017.0174. Epub 2018 Jul 31. PMID: 30063169. [Link] Links and References: * Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. _Am J Psychiatry_. 2007 Sep;164(9):1356-63. doi:" [Link] * Gibbons RD, Brown CH, Hur K, Davis J, Mann JJ. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry. 2012 Jun;69(6):580-7. doi: 10.1001/archgenpsychiatry.2011.2048. Erratum in: Arch Gen Psychiatry.2013 Aug;70(8):881. PMID: 22309973; PMCID: PMC3367101. [Link] * Findling RL, Robb A, Bose A. Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial._ J Child Adolesc Psychopharmacol_. 2013 Sep;23(7):468-80. doi: 10.1089/cap.2012.0023. PMID: 24041408; PMCID: PMC3779002. [Link] * Healy D, Cattell D. Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatry. 2003 Jul;183:22-7. PMID: 12835239. [Link] * Phase Five Website [Link] * Phase Five Marketing Document [Link]
25 min
Inside Schizophrenia
Inside Schizophrenia
Healthline Media
Incarceration and Schizophrenia
The U.S. correctional system is responsible for having 10 times the number of mentally ill patients receiving treatment than any state psychiatric hospital. People with serious mental disorders are 4 times more likely to be incarcerated for minor charges, such as disorderly conduct. Inmates with schizophrenia also remain in prison longer than others. Host Rachel Star Withers and cohost Gabe Howard examine the effect prison has on people with schizophrenia and the connections between living with schizophrenia and incarceration. Guest Lloyd Hale joins us to discuss living with schizophrenia and his time in the correctional system after he was convicted of murder. Years later, he was found not guilty by reason of insanity. About Our Guest Lloyd Hale is a father, certified peer specialist, and the founder of RIDE 4 S.P.M.I. (Ride 4 Serious and Persistent Mental Illness), a 210-mile bike ride across South Carolina to raise awareness around mental illness. As someone living well with schizophrenia, Lloyd has devoted his life to sharing his story in the hopes that others will seek treatment and receive the help and support they need. Lloyd has partnered with SC SHARE (South Carolina Self Help Association Regarding Emotions) to champion the READY FOR LIFE project and THE DREAM TEAM PROJECT, which aims to start healthy conversations in rural areas with youths and their families about mental health and resources in their community. Featured in the Bevocalspeakup documentary “Beyond Silence” with executive producer, singer and songwriter Demi Lovato. In the documentary, Lloyd shares an unscripted journey with the camera through his recovery and current life.
1 hr 4 min
More episodes
Clear search
Close search
Google apps
Main menu